Kymera Therapeutics Inc (KYMR)

Cash & Equivalents

$124.48M

Quarterly · Period ending: · USD

KYMR logo

KYMR Cash & Equivalents

Latest reported$124.48M
KYMR Quarterly Cash & Equivalents ($76.02M → $124.48M)
High-resolution chart · PNG

KYMR cash & equivalents history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Kymera Therapeutics Inc Cash & Equivalents — Quarterly (USD)
Period endingCash & Equivalents (USD)
124,477,000
144,090,000
357,011,000
112,949,000
335,816,000
89,966,000
120,256,000
110,718,000
67,612,000
93,510,000
109,966,000
81,051,000
52,386,000
50,152,000
68,395,000
155,658,000
76,914,000
33,733,000
47,976,000
156,819,000
84,903,000
53,098,000
31,004,000
54,593,000
60,971,000
76,015,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.